Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5427_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
10 Мб
Скачать
☆
2 Fused Deposition Modeling (FDM) of Pharmaceuticals 87
and rheological behaviour. These limitations might lengthen the research and development phase of printed dosage forms and hamper their clinical translation. Adaptations of existing equipment, invention of new feeding approaches or devel­opment of new feedstock material could facilitate tapping into its full potential (Abdelhamid et al.,
In 2015, the first 3D-printed product received FDA approval. The product, called Spiritam, was developed by Aprecia Pharmaceuticals using the ZipDose technology with powder 3D-printing. It was an orodispersible tablet loaded with levetiracetam for the treatment of epilepsy. Despite this earlier approval, there are unfortunately no regulatory guidelines available yet for 3D-printed drug products. Development of universal guidelines implies a strenuous task due to the variety of 3D-printing techniques and personalization of its products. Individual efficiency and risk assessment for each developed product might be required, which could hamper fast implementation in healthcare. Moreover, ambiguity exists about whether or not 3D-printing classifies as production or compounding technique, which will greatly affect regulatory requirements (Auriemma et al.,
Another aspect to keep in mind is the fact that the production rate of FDM 3D­printing is rather slow in comparison with traditional manufacturing techniques, making the technique unsuitable for mass production. Flexible, batch-wise produc­tion remains one of the strengths of FDM 3D-printing (Parulski et al., it is anticipated that 3D-printing will not entirely replace traditional manufacturing but act as a complementary production technique, suitable for specific cases where personalization is highly desirable.
2022; Henry et al., 2021a)
2022).
2021). Hence,
2.7 Conclusion
In the recent years, fused deposition modeling 3D-printing has become a popu­lar technology in the field of pharmaceutical research. While the process itself seems simple, its implementation in pharmaceutical production is challenging. The mechanical properties and viscoelastic behaviour of the feedstock material dictate its processability with the FDM printer, limiting the portfolio of applicable pharmaceutical materials. Addition of processing aids or blending of polymers might strengthen the filament or lower its viscosity, hence resulting in new, printable formulations. The development of screening tools like tensile tests or small amplitude oscillatory shear tests might enable a structured investigation of complex formulations, while avoiding costly and time-consuming trial-and-error approaches. Alternatively, melt printing techniques utilizing alternative feedstock materials (e.g. pellets, powders) are also under development.
Once a printable formulation has been developed, personalization of the drug product by designing a tailored dosage form and incorporating a specific drug (load) becomes decisive. Both in-silico model parameters and process settings should be optimized to obtain a qualitative end-product with acceptable mechanical properties and the required drug release profile. A variety of traditional and novel
88 S. Henry et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
characterization techniques have been explored for 3D-printed drug products to ensure that quality is built-in into the process.
The potential of FDM 3D-printing has been confirmed by numerous research groups through development and characterization of miscellaneous innovative dosage forms like oral tablets, transdermal films or implants. Nonetheless, before this technique can be fully implemented to produce personalized dosage forms on-site, the efficiency and reliability of 3D printers should be improved. Gradual optimization of the production process and expansion of the proficiency for printing by researchers might enable this technique to truly revolutionize pharmaceutical manufacturing.
References
Abdelhamid M, Koutsamanis I, Corzo C, Maisriemler M, Ocampo AB, Slama E, Alva C,
Lochmann D, Reyer S, Freichel T, Salar-Behzadi S, Spoerk M (2022) Filament-based 3D­printing of placebo dosage forms using brittle lipid-based excipients. Int J Pharm 624(July):1– 12
Aho J, Boetker JP, Baldursdottir S, Rantanen J (2015) Rheology as a tool for evaluation of melt
processability of innovative dosage forms. Int J Pharm 494(2):623–642
Aho J, Bøtker JP, Genina N, Edinger M, Arnfast L, Rantanen J (2019) Roadmap to 3D-printed
oral pharmaceutical dosage forms: feedstock filament properties and characterization for fused deposition modeling. J Pharm Sci 108(1):26–35
Alhijjaj M, Nasereddin J, Belton P, Qi S (2019) Impact of processing parameters on the
quality of pharmaceutical solid dosage forms produced by fused deposition modeling (FDM). Pharmaceutics 11(633):1–21
Antonara L, Dallas PP, Rekkas DM (2022) A novel 3D printing enabled method for fast and reliable
construction of polymeric microneedles using experimental design. J Drug Delivery Sci Technol 68(102888):1–11
Auriemma G, Tommasino C, Falcone G, Esposito T, Sardo C, Aquino RP (2022) Additive
manufacturing strategies for personalized drug delivery systems and medical devices: fused filament fabrication and semi solid extrusion. Molecules 27(9)
Awad A, Trenfield SJ, Gaisford S, Basit AW (2018) 3D printed medicines: a new branch of digital
healthcare. Int J Pharm 548(1):586–596
Ayyoubi, S., Cerda, J.R., Fernández-García R, Knief P, Lalatsa A, Healy AM, Serrano DR
(2021) 3D printed spherical mini-tablets: geometry versus composition effects in controlling dissolution from personalised solid dosage forms. Int J Pharm 597(December 2020):1–15
Azad MA, Olawuni D, Kimbell G, Md. Badruddoza AZ, Md. Hossain S, Sultana T (2020)
Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials–process perspective. Pharmaceutics 12(2):1–34
Azizo˘glu E, Özer Ö (2020) Fabrication of Montelukast sodium loaded filaments and 3D printing
transdermal patches onto packaging material. Int J Pharm 587(June):119588
Baldi F, Briatico-vangosa F, Franceschini A, Leonardo P, Milano I (2014) Experimental study of
the melt fracture behavior of filled high-density polyethylene melts. Polym Eng Sci 54:364–377 Barnes HA (2003) A review of the rheology of filled viscoelastic systems. Rheol Rev 1:1–36 Barrios-Muriel J, Romero-Sánchez F, Alonso-Sánchez FJ, Salgado DR (2020) Advances in
orthotic and prosthetic manufacturing: a technology review. Materials 13(2):1–15 Beck RCR, Chaves PS, Goyanes A, Vukosavljevic B, Buanz A, Windbergs M, Basit AW, Gaisford
S (2017) 3D printed tablets loaded with polymeric nanocapsules: an innovative approach to
produce customized drug delivery systems. Int J Pharm 528(1–2):268–279
2 Fused Deposition Modeling (FDM) of Pharmaceuticals 89
Boniatti J, Januskaite P, da Fonseca LB, Viçosa AL, Amendoeira FC, Tuleu C, Basit AW, Goyanes
A, Ré MI (2021) Direct powder extrusion 3d printing of praziquantel to overcome neglected
disease formulation challenges in paediatric populations. Pharmaceutics 13(8):1–19 Cailleaux S, Sanchez-Ballester NM, Gueche YA, Bataille B, Soulairol I (2021) Fused deposition
modeling (FDM), the new asset for the production of tailored medicines. J. Control. Release
330(October 2020):821–841 Carneiro OS, Silva AF, Gomes, R (2015) Fused deposition modeling with polypropylene. Mater
Des 83:768–776 Cerda JR, Arifi T, Ayyoubi S, Knief P, Ballesteros MP, Keeble W, Barbu E, Healy AM, Lalatsa
A, Serrano DR (2020) Personalised 3d printed medicines: optimising material properties for
successful passive diffusion loading of filaments for fused deposition modelling of solid dosage
forms. Pharmaceutics 12(4):1–24 Ceretti DVA, Fiorio R, Van Waeleghem T, Desmet A, Florizoone B, Cardon L, D’hooge DR (2022)
Exploiting mono- and hybrid nanocomposite materials for fused filament.pdf. J Appl Polym Sci
e52922:1–21 Chai X, Chai H, Wan X, Yang J, Li J, Zhao Y, Cai W (2017) Fused deposition modeling (FDM)
3D printed tablets for intragastric floating delivery of domperidone. Nat Sci Rep 7(2829):1–9 Chamberlain R, Windolf H, Geissler S, Quodbach J (2022) Precise dosing of pramipexole
for low-dosed filament production by hot melt extrusion applying various feeding methods.
Pharmaceutics 14(216):1–17 Chaudhari VS, Malakar TK, Murty US, Banerjee S (2021) Extruded filaments derived 3D printed
medicated skin patch to mitigate destructive pulmonary tuberculosis: design to delivery. Expert
Opin Drug Deliv 18(2):301–313 Cicala G, Giordano D, Tosto C, Filippone G, Recca A, Blanco I (2018) Polylactide (PLA) filaments
a biobased solution for additive manufacturing: correlating rheology and thermomechanical
properties with printing quality. Materials 11(7):1–13 Cri¸san AG, Iurian S, Porfire A, Rus LM, Bogdan C, Casian T, Lucacel RC, Turza A, Porav S,
Tomu¸t˘a I (2022) QbD guided development of immediate release FDM-3D printed tablets with
customizable API doses. Int J Pharm 613(October 2021):1–20 Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, McGinity JW, Martin
C (2007) Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm
33(9):909–926 Dawood A, Marti Marti B, Sauret-Jackson V, Darwood A (2015) 3D printing in dentistry. Br Dent
J 219(11):521–529 De Oliveira RS, Fantaus SS, Jos A, Melero A, Carlos R, Beck R (2021) 3D-printed products
for topical skin applications: from personalized dressings to drug delivery. Pharmaceutics
13(1946):1–39 Derakhshandeh H, Aghabglou F, McCarthy A, Mostafavi A, Wiseman C, Bonick Z, Ghanavati
I, Harris S, Kreikemeier-Bower C, Masoud S, Rosebohm J, Yang R, Mostafalu P, Orgill D,
Tamayol A (2020) A wirelessly controlled smart bandage with 3D-printed miniaturized needle
arrays. Adv Funct Mat 30(1905544) Domínguez-Robles J, Martin NK, Fong ML, Stewart SA, Irwin NJ, Rial-Hermida MI, Donnelly
RF, Larrañeta E (2019) Antioxidant PLA composites containing lignin for 3D printing
applications: a potential material for healthcare applications. Pharmaceutics 11(4):5–7 Domínguez-Robles J, Utomo E, Cornelius VA, Anjani QK, Korelidou A, Gonzalez Z, Donnelly
RF, Margariti A, Delgado-Aguilar M, Tarrés Q, Larrañeta E (2022) TPU-based antiplatelet
cardiovascular prostheses prepared using fused deposition modelling. Mat Design 220:1–14 Domsta V, Seidlitz A (2021) 3D-printing of drug-eluting implants: an overview of the current
developments described in the literature. Molecules 26(4066) Ehtezazi T, Algellay M, Islam Y, Roberts M, Dempster NM, Sarker SD (2018) The application
of 3D printing in the formulation of multilayered fast dissolving oral films. J Pharm Sci
107(4):1076–1085 Elbadawi M (2018). Polymeric additive manufacturing: the necessity and utility of rheology. In:
Rivera-Armenta, JL, Cruz, BAS (eds) Polymer Rheology
90 S. Henry et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Elbadawi M, Castro BM, Gavins FKH, Ong JJ, Gaisford S, Pérez G, Basit AW, Cabalar P, Goyanes
A (2020) M3DISEEN: a novel machine learning approach for predicting the 3D printability of
medicines. Int J Pharm 590(August):119837 Elbadawi M, Gustaffson T, Gaisford S, Basit AW (2020) 3D printing tablets: predicting printability
and drug dissolution from rheological data. Int J Pharm 590(September):119868 Eleftheriadis GK, Monou PK, Bouropoulos N, Boetker J, Rantanen J, Jacobsen J, Vizirianakis
IS, Fatouros DG (2020) Fabrication of mucoadhesive buccal films for local Administration of
Ketoprofen and Lidocaine hydrochloride by combining fused deposition modeling and inkjet
printing. J Pharm Sci 109(9):2757–2766 Elkanayati RM, Chambliss WG, Omari S, Almutairi M, Repka MA, Ashour EA (2022) Journal of
Drug Delivery Science and Technology Mucoadhesive buccal films for treatment of xerostomia
prepared by coupling HME and 3D printing technologies. J Drug Delivery Sci Technol
75(August):103660 Feuerbach T, Thommes M (2021) Design and characterization of a screw extrusion hot-end for
fused deposition modeling. Molecules 26(590):1–10 Fico D, Rizzo D, Casciaro R, Corcione CE (2022) A review of polymer-based materials for fused
filament fabrication (FFF): focus on sustainability and recycled materials. Polymers 14(3):1–33 Fu J, Yu X, Jin Y (2018) 3D printing of vaginal rings with personalized shapes for controlled
release of progesterone. Int J Pharm 539(1–2):75–82 Fuenmayor E, Forde M, Healy AV, Devine DM, Lyons JG, McConville C, Major I (2018) Material
considerations for fused-filament fabrication of solid dosage forms. Pharmaceutics 10(2):1–27 Genina N, Holländer J, Jukarainen H, Mäkilä E, Salonen J, Sandler N (2016) Ethylene vinyl acetate
(EVA) as a new drug carrier for 3D printed medical drug delivery devices. Eur J Pharm Sci
90:53–63 Gioumouxouzis CI, Katsamenis OL, Bouropoulos N, Fatouros DG (2017) 3D printed oral solid
dosage forms containing hydrochlorothiazide for controlled drug delivery. J Drug Delivery Sci
Technol 40:164–171 Gioumouxouzis CI, Baklavaridis A, Katsamenis OL, Markopoulou CK, Bouropoulos N, Tzetzis
D, Fatouros DG (2018) A 3D printed bilayer oral solid dosage form combining metformin for
prolonged and glimepiride for immediate drug delivery. Eur J Pharm Sci 120(January):40–52 Gioumouxouzis CI, Karavasili C, Fatouros DG (2019) Recent advances in pharmaceutical dosage
forms and devices using additive manufacturing technologies. Drug Discov Today 24(2):636–
643 Gioumouxouzis CI, Tzimtzimis E, Katsamenis OL, Dourou A, Markopoulou C, Bouropoulos
N, Tzetzis D, Fatouros DG (2020) Fabrication of an osmotic 3D printed solid dosage form
for controlled release of active pharmaceutical ingredients. Eur J Pharm Sci 143(August
2019):105176
Giri BR, Song ES, Kwon J, Lee J-h, Park J-b (2020) Fabrication of intragastric floating, controlled
release 3D printed theophylline tablets using hot-melt extrusion and fused deposition modeling.
Pharmaceutics 12(77):1–16 Gosselin C, Duballet R, Roux P, Gaudillière N, Dirrenberger J, Morel P (2016) Large-scale 3D
printing of ultra-high performance concrete – a new processing route for architects and builders.
Mater Des 100:102–109 Gottschalk N, Bogdahn M, Harms M, Quodbach J (2021) Brittle polymers in fused deposition
modeling: an improved feeding approach to enable the printing of highly drug loaded filament.
Int J Pharm 597(120216):1–11 Gottschalk N, Quodbach J, Elia AG, Hess F, Bogdahn M (2022) Determination of feed forces to
improve process understanding of Fused Deposition Modeling 3D printing and to ensure mass
conformity of printed solid oral dosage forms. Int J Pharm 614(September 2021):121416 Goyanes A, Buanz ABM, Basit AW, Gaisford S (2014) Fused- filament 3D printing (3DP) for
fabrication of tablets. Int J Pharm 476:88–92 Goyanes A, Chang H, Sedough D, Hatton GB, Wang J, Buanz A, Gaisford S, Basit AW (2015)
Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int J Pharm
496(2):414–420
2 Fused Deposition Modeling (FDM) of Pharmaceuticals 91
Goyanes A, Wang J, Buanz A, Telford R, Gaisford S, Basit AW (2015) 3D printing of medicines:
engineering novel oral devices with unique design and drug release characteristics. Mol Pharm
12:4077–4084 Goyanes A, Det-Amornrat U, Wang J, Basit AW, Gaisford S (2016) 3D scanning and 3D printing
as innovative technologies for fabricating personalized topical drug delivery systems. J Control
Release 234:41–48 Goyanes A, Allahham N, Tren SJ, Stoyanov E, Gaisford S, Basit AW (2019) Direct powder
extrusion 3D printing: fabrication of drug products using a novel single-step process. Int J Pharm
567(118471) Gültekin HE, Tort S, Acartürk F (2019) An effective technology for the development of immediate
release solid dosage forms containing low-dose drug: fused deposition modeling 3D printing.
Pharm Res 36(9):1–13 Henry S, Samaro A, Marchesini FH, Shaqour B, Macedo J, Vanhoorne V, Vervaet C (2021a)
Extrusion-based 3D printing of oral solid dosage forms: material requirements and equipment
dependencies. Int J Pharm 598(December 2020):120361 Henry S, De Vadder L, Decorte M, Francia S, Steenkiste MV, Saevels J, Vanhoorne V, Vervaet C
(2021b) Development of a 3D-printed dosing platform to aid in zolpidem withdrawal therapy.
Pharmaceutics 13(1684):1–24 Henry S, De Wever L, Vanhoorne V, De Beer T, Vervaet C (2021c) Influence of print settings on the
critical quality attributes of extrusion-based 3D-printed caplets: a quality-by-design approach.
Pharmaceutics 13(2068):1–13 Holländer J, Genina N, Jukarainen H, Khajeheian M, Rosling A, Mäkilä E, Sandler N (2016)
Three-dimensional printed PCL-based implantable prototypes of medical devices for controlled
drug delivery. J Pharm Sci 105(9):2665–2676 Ilyés K, Kovács NK, Balogh A, Borbás E, Farkas B, Casian T, Marosi G, Tomu¸t˘a I, Kristóf Nagy Z
(2019) The applicability of pharmaceutical polymeric blends for the fused deposition modelling
(FDM) 3D technique: material considerations–printability–process modulation, with consecu-
tive effects on in vitro release, stability and degradation. Eur J Pharm Sci 129(January):110–123 Isreb A, Baj K, Wojsz M, Isreb M, Peak M, Alhnan MA (2019) 3D printed oral theophylline doses
with innovative ‘radiator-like’ design: impact of polyethylene oxide (PEO) molecular weight.
Int J Pharm 564(April):98–105 Jamróz W, Szafraniec J, Kurek M, Jachowicz R (2018) 3D printing in pharmaceutical and medical
applications. Pharm Res 35(9):Article 176:1–20 Jamroz W, Pyteraf J, Kurek M, Knapik-kowalczuk J, Szafraniec-szcz J, Jurkiewicz K, Leszczy B
(2020) Multivariate design of 3D printed immediate-release tablets with liquid crystal-forming
drug-itraconazole. Materials 13(4961) Joseph B, Ninan N, Visalakshan RM, Denoual C, Bright R, Kalarikkal N, Grohens Y, Vasilev K,
Thomas S (2021) Insights into the biomechanical properties of plasma treated 3D printed PCL
scaffolds decorated with gold nanoparticles. Compos Sci Technol 202(108544):1–12 Kempin W, Franz C, Koster LC, Schneider F, Bogdahn M, Weitschies W, Seidlitz A (2017)
Assessment of different polymers and drug loads for fused deposition modeling of drug loaded
implants. Eur J Pharm Biopharm 115:84–93 Kempin W, Domsta V, Grathoff G, Brecht I, Semmling B, Tillmann S, Weitschies W, Seidlitz
A (2018) Immediate release 3D-printed tablets produced via fused deposition modeling of a
thermo-sensitive drug. Pharm Res 35(6):1–12 Kollamaram G, Croker DM, Walker GM, Goyanes A, Basit AW, Gaisford S (2018) Low
temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Int J Pharm
545(1–2):144–152 Kolter K, Karl M, Gryczke A (2012) Hot-melt extrusion with BASF pharma polymers – extrusion
compendium. BASF SF, Ludwigshafen Korte C, Quodbach J, Korte C, Quodbach J (2018) Formulation development and process
analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of
medicines manufactured via hot-melt extrusion for 3D-printing of medicines. Pharm Dev
Technol 23(10):1117–1127
92 S. Henry et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Koutsamanis I, Paudel A, Alva Zúñiga CP, Wiltschko L, Spoerk M (2021) Novel polyester-
based thermoplastic elastomers for 3D-printed long-acting drug delivery applications. J Control
Release 335(March):290–305 Kumar P, Maddikunta R, Pham Q-v, Prabadevi B, Deepa N, Dev K, Reddy T, Ruby R, Liyanage
M (2022) Industry 5.0: a survey on enabling technologies and potential applications. J Ind Inf
Integ 26(100257) Lamichhane S, Park J-b, Sohn DH, Lee S (2019) Customized novel design of 3D printed pregabalin
tablets for intra-gastric floating and controlled release using fused deposition modeling.
Pharmaceutics 11(564):1–9 Ligon SC, Liska R, Stampfl J, Gurr M, Mülhaupt R (2017) Polymers for 3D printing and
customized additive manufacturing. Chem Rev 117(15):10212–10290 Lima AL, Pires FQ, Hilgert LA, Sa-Barreto LL, Gratieri T, Gelfuso GM, Cunha-Filho M (2022)
Oscillatory shear rheology as an in-process control tool for 3D printing medicines production
by fused deposition modeling. J Manuf Process 76(February):850–862 Linares V, Casas M, Caraballo I (2019) Printfills: 3D printed systems combining fused deposition
modeling and injection volume fi lling. Application to colon-specific drug delivery. Eur J Pharm
Biopharm 134(August 2018):138–143 Long J, Nand AV, Ray S, Mayhew S, White D, Bunt CR, Seyfoddin A (2018) Development of cus-
tomised 3D printed biodegradable projectile for administrating extended-release contraceptive
to wildlife. Int J Pharm 548(1):349–356 MacDonald E, Salas R, Espalin D, Perez M, Aguilera E, Muse D, Wicker RB (2014) 3D printing
for the rapid prototyping of structural electronics. IEEE Access 2:234–242 Macedo J, Samaro A, Vanhoorne V, Vervaet C, Pinto JF (2020) Processability of poly (vinyl
alcohol) based filaments with paracetamol prepared by hot-melt extrusion for additive manu-
facturing. J Pharm Sci 109:3636–3644 Macedo J, da Costa NF, Vanhoorne V, Vervaet C, Pinto JF (2022) The precision and accuracy of
3D printing of tablets by fused deposition modelling. J Pharm Sci 000:1–13 Markl D, Sauerwein J, Goodwin DJ, Van Den Ban S, Axel Zeitler J (2017) Non-destructive
determination of disintegration time and dissolution in immediate release tablets by terahertz
transmission measurements. Pharm Res 34:1012–1022 Markl D, Strobel A, Schlossnikl R, Bøtker J, Bawuah P, Ridgway C, Rantanen J, Rades T, Gane P,
Peiponen K-e, Zeitler JA (2018) Characterisation of pore structures of pharmaceutical tablets: a
review. Int J Pharm 538(1–2):188–214 Maroni A, Melocchi A, Parietti F, Foppoli A, Zema L, Gazzaniga A (2017) 3D printed
multi-compartment capsular devices for two-pulse oral drug delivery. J Control Release
268(August):10–18 Martin C (2016) Twin screw extruders as continuous mixers for thermal processing: a technical
and historical perspective. AAPS PharmSciTech 17(1):3–19 McDonagh T, Belton P, Qi S (2022) Direct granule feeding of thermal droplet deposition 3D
printing of porous pharmaceutical solid dosage forms free of plasticisers. Pharm Res 39(3):599–
610 Masood SH, Song WQ (2004) Development of new metal/polymer materials for rapid tooling
using fused deposition modelling. Mater Des 25(7):587–594 Melocchi A, Parietti F, Maroni A, Foppoli A, Gazzaniga A, Zema L (2016) Hot-melt extruded
filaments based on pharmaceutical grade polymers for 3D printing by fused deposition
modeling. Int J Pharm 509(1–2):255–263 Muwaffak Z, Goyanes A, Clark V, Basit AW, Hilton ST, Gaisford S (2017) Patient-specific 3D
scanned and 3D printed antimicrobial polycaprolactone wound dressings. Int J Pharm 527(1–
2):161–170
Nasereddin JM, Wellner N, Alhijjaj M, Belton P, Qi S (2018) Development of a simple mechanical
screening method for predicting the feedability of a pharmaceutical FDM 3D printing filament.
Pharm Res 35(8):1–13
2 Fused Deposition Modeling (FDM) of Pharmaceuticals 93
Novak M, Boleslavská T, Wan A, Beránek J, Kova P (2018) Virtual prototyping and parametric
design of 3D-printed tablets based on the solution of inverse problem. AAPS PharmSciTech
19(8):3414–3424 Nukala PK, Palekar S, Solanki N, Fu Y, Patki M, Sohatee AA, Trombetta L, Patel K (2019a)
Investigating the application of FDM 3D printing pattern in preparation of patient-tailored
dosage forms. J 3D Print Med 3(1):23–37 Nukala PK, Palekar S, Patki M, Patel K (2019b) Abuse deterrent immediate release egg-shaped
tablet (egglets) using 3D printing technology: quality by design to optimize drug release and
extraction. AAPS PharmSciTech 20(80):1–16 Okwuosa TC, Stefaniak D, Arafat B, Isreb A, Wan KW, Alhnan MA (2016) A lower temperature
FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm Res
33(11):2704–2712 Okwuosa TC, Pereira BC, Arafat B, Cieszynska M, Isreb A, Alhnan MA (2017) Fabricating a shell-
core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res
34(2):427–437 Okwuosa TC, Soares C, Gollwitzer V, Habashy R, Timmins P, Alhnan MA (2018) On demand
manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid
dispensing. Eur J Pharm Sci 118(February):134–143 Oladeji S, Mohylyuk V, Jones DS, Andrews GP (2022) 3D printing of pharmaceutical oral solid
dosage forms by fused deposition: the enhancement of printability using plasticised HPMCAS.
Int J Pharm 616(February):121553 Omari S, Ashour EA, Elkanayati R, Alyahya M, Almutairi M, Repka MA (2022) Formulation
development of loratadine immediate- release tablets using hot-melt extrusion and 3D printing
technology. J Drug Delivery Sci Technol 74(June):103505 Ong JJ, Castro BM, Gaisford S, Cabalar P, Basit AW, Pérez G, Goyanes A (2022) Accelerating 3D
printing of pharmaceutical products using machine learning. Int J Pharm X 4(April):1–11 Palekar S, Nukala PK, Patel K (2022) Aversion liquid-filled drug releasing capsule (3D-RECAL):
a novel technology for the development of immediate release abuse deterrent formulations using
a fused deposition modelling (FDM) 3D printer. Int J Pharm 621(April):121804 Parulski C, Jennotte O, Lechanteur A, Evrard B (2021) Challenges of fused deposition modeling
3D printing in pharmaceutical applications: Where are we now? Adv Drug Deliv Rev 175:1–18 Parulski C, Gresse E, Jennotte O, Felten A, Ziemons E, Lechanteur A, Evrard B (2022) Fused
deposition modeling 3D printing of solid oral dosage forms containing amorphous solid
dispersions: how to elucidate drug dissolution mechanisms through surface spectral analysis
techniques? Int J Pharm 626(June):122157 Pereira BC, Isreb A, Forbes RT, Dores F, Habashy R, Petit JB, Alhnan MA, Oga EF (2019)
‘Temporary Plasticiser’: a novel solution to fabricate 3D printed patient-centred cardiovascular
‘Polypill’ architectures. Eur J Pharm Biopharm 135(December 2018):94–103 Pereira GG, Figueiredo S, Fernandes AI, Pinto JF (2020) Polymer selection for hot-melt extrusion
coupled to fused deposition modelling in pharmaceutics. Pharmaceutics 12(9):1–63 Pietrzak K, Isreb A, Alhnan MA (2015) A flexible-dose dispenser for immediate and extended
release 3D printed tablets. Eur J Pharm Biopharm 96:380–387 Ponsar H, Wiedey R, Quodbach J (2020) Hot-melt extrusion process fluctuations and their impact
on critical quality attributes of filaments and 3d-printed dosage forms. Pharmaceutics 12(6):1–
15 Pranzo D, Larizza P, Filippini D, Percoco G (2018) Extrusion-based 3D printing of microfluidic
devices for chemical and biomedical applications: A topical review. Micromachines 9(8):1–27 Prasad E, Islam MT, Goodwin DJ, Megarry AJ, Halbert GW, Florence AJ, Robertson J (2019)
Development of a hot-melt extrusion (HME) process to produce drug loaded Affinisol™
15LV filaments for fused filament fabrication (FFF) 3D printing. Addit Manuf 29(October
2018):100776
Prasad E, Robertson J, Halbert GW (2020) Solid dispersions: improving drug performance through
tablet micro-structure design. In: AAPS PharmSci360
94 S. Henry et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Quodbach J, Bogdahn M, Breitkreutz J, Chamberlain R, Eggenreich K, Elia AG, Gottschalk N,
Gunkel-Grabole G, Hoffmann L, Kapote D, Kipping T, Klinken S, Loose F, Marquetant T,
Windolf H, Geißler S, Spitz T (2021) Quality of FDM 3D printed medicines for pediatrics:
considerations for formulation development, filament extrusion, printing process and printer
design. Ther Innov Regul Sci (0123456789):910–928 Sadia M, So´snicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, Alhnan MA (2016) Adaptation of
pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate
release tablets. Int J Pharm 513(1–2):659–668 Sadia M, Isreb A, Abbadi I, Isreb M, Aziz D, Selo A, Timmins P, Alhnan MA (2018) From ‘fixed
dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets.
Eur J Pharm Sci 123(July):484–494 Sadia M, Arafat B, Ahmed W, Forbes RT, Alhnan MA (2018) Channelled tablets: an innovative
approach to accelerating drug release from 3D printed tablets. J Control Release 269(September
2017):355–363
Samaro A, Janssens P, Vanhoorne V, Van Renterghem J, Eeckhout M, Cardon L, De Beer T, Vervaet
C (2020) Screening of pharmaceutical polymers for extrusion-based additive manufacturing of
patient-tailored tablets. Int J Pharm 586(June):1–11 Samaro A, Shaqour B, Goudarzi NM, Ghijs M, Cardon L, Boone MN, Verleije B, Beyers K,
Vanhoorne V, Cos P, Vervaet C (2021) Can filaments, pellets and powder be used as feedstock
to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based
additive manufacturing? Int J Pharm 607(June):1–11 Santos JD, da Silva GS, Velho MC, Beck RCR (2021) Eudragit®: a versatile family of polymers
for hot melt extrusion and 3D printing processes in pharmaceutics. Pharmaceutics 13(9):1–36 Schneider C, Langer R, Loveday D, Hair D (2017) Applications of ethylene vinyl acetate
copolymers (EVA) in drug delivery systems. J Control Release 262(August):284–295 Scoutaris N, Ross SA, Douroumis D (2018) 3D printed “starmix” drug loaded dosage forms for
paediatric applications. Pharm Res 35(2):1–11 Serdeczny MP, Comminal R, Pedersen DB, Spangenberg J (2020) Experimental and analytical
study of the polymer melt flow through the hot- end in material extrusion additive manufactur-
ing. Addit Manuf 32(100997):1–13 Shaqour B, Samaro A, Verleije B, Beyers K, Vervaet C (2020) Production of drug delivery systems
using fused filament fabrication: a systematic review. Pharmaceutics 12:1–16 Shi K, Slavage JP, Maniruzzaman M, Nokhodchi A (2021) Role of release modifiers to mod-
ulate drug release from fused deposition modelling (FDM) 3D printed tablets. Int J Pharm
597(December 2020):120315 Solanki NG, Tahsin Md., Shah AV, Serajuddin ATM (2018) Formulation of 3D printed tablet for
rapid drug release by fused deposition modeling: screening polymers for drug release, drug-
polymer miscibility and printability. J Pharm Sci 107(1):390–401 Spoerk M, Arbeiter F, Koutsamanis I, Cajner H, Katschnig M, Eder S (2021) Personalised
urethra pessaries prepared by material extrusion-based additive manufacturing. Int J Pharm
608(September):121112 Stewart SA, Domínguez-Robles J, McIlorum VJ, Mancuso E, Lamprou DA, Donnelly RF,
Larrañeta E (2020) Development of a biodegradable subcutaneous implant for prolonged drug
delivery using 3D printing. Pharmaceutics 12(2):1–16 Tagami T, Kuwata E, Sakai N, Ozeki T (2019) Drug incorporation into polymer filament using
simple soaking method for tablet preparation using fused deposition modeling. Biol Pharm Bull
42(10):1753–1760 Tan DK, Maniruzzaman M, Nokhodchi A (2020) Development and optimisation of novel
polymeric compositions for sustained release theophylline. Polymers 12(1):1–18 Teo EY, Ong SY, Chong MSK, Zhang Z, Lu J, Moochhala S, Ho B, Teoh SH (2011)
Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to
infected wounds. Biomaterials 32(1):279–287 Than YM, Titapiwatanakun V (2021) Tailoring immediate release FDM 3D printed tablets using a
quality by design (QbD) approach. Int J Pharm 599(January):120402
2 Fused Deposition Modeling (FDM) of Pharmaceuticals 95
Than YM, Suriyarak S, Titapiwatanakun V (2022) Rheological investigation of hydroxypropyl
cellulose–based filaments for material extrusion 3D printing. Polymers 14(6):1–24 Tidau M, Finke JH, Kwade A, Braunschweig TU, Pharmaceutical Engineering (2019) Influence
of high API load on properties along the 3D- printing process chain of solid dosage forms.
Pharmaceutics 11(194):1–17 Tlegenov Y, Hong GS, Lu WF (2018) Nozzle condition monitoring in 3D printing. Robot Comput
Integr Manuf 54(May):45–55 Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW (2018) 3D printing pharmaceuticals: drug
development to frontline care. Trends Pharmacol Sci 39(5):440–451 Turner BN, Strong R, Gold SA (2014) A review of melt extrusion additive manufacturing
processes: I. Process design and modeling. Rapid Prototyp J 20(3):192–204 Verstraete G, Samaro A, Grymonpre W, Vanhoorne V, Van Snick B, Boone MN, Hellemans T, Van
Hoorebeke L, Remon JP, Vervaet C (2018) 3D printing of high drug loaded dosage forms using
thermoplastic polyurethanes. Int J Pharm 536(1):318–325 Viidik L, Vesala J, Laitinen R, Korhonen O, Ketolainen J, Aruväli J, Kirsimäe K, Kogermann
K, Heinämäki J, Laidmäe I, Ervasti T (2021) Preparation and characterization of hot-melt
extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Eur J Pharm
Sci 158(October 2020):1–8 Vo AQ, Zhang J, Nyavanandi D, Bandari S, Repka MA (2020) Hot melt extrusion paired fused
deposition modeling 3D printing to develop hydroxypropyl cellulose based floating tablets of
cinnarizine. Carbohydr Polym 246(March):116519 Wang YC, Chen T, Yeh YL (2019) Advanced 3D printing technologies for the aircraft industry:
a fuzzy systematic approach for assessing the critical factors. Int J Adv Manuf Technol
105(10):4059–4069 Welsh NR, Malcolm RK, Devlin B, Boyd P (2019) Dapivirine-releasing vaginal rings produced by
plastic freeforming additive manufacturing. Int J Pharm 572(September):118725 Wei C, Solanki NG, Vasoya JM, Shah AV, Serajuddin ATM (2020) Development of 3D printed
tablets by fused deposition modeling using polyvinyl alcohol as polymeric matrix for rapid
drug release. J Pharm Sci 109(4):1558–1572 Windolf H, Chamberlain R, Breitkreutz J, Quodbach J (2022) 3D printed mini-floating-polypill for
Parkinson’s disease: combination of levodopa, benserazide, and pramipexole in various dosing
for personalized therapy. Pharmaceutics 14(5):1–7 Windolf H, Chamberlain R, Delmotte A, Quodbach J (2022) Blind-watermarking–proof-of-
concept of a novel approach to ensure batch traceability for 3D printed tablets. Pharmaceutics
14(2):1–22 Wu Z, Hong Y (2019) Combination of the silver-ethylene interaction and 3D printing to
develop antibacterial superporous hydrogels for wound management. ACS Appl Mat Interfaces
11(37):33734–33747 Xu P, Li J, Meda A, Osei-Yeboah F, Peterson ML, Repka M, Zhan X (2020) Development of a
quantitative method to evaluate the printability of filaments for fused deposition modeling 3D
printing. Int J Pharm 588(August):119760 Yadav DK, Srivastava R, Dev S (2019) Design & fabrication of ABS part by FDM for automobile
application. Mater Today Proc 26:2089–2093 Yang Y, Wang H, Li H, Ou Z, Yang G (2018) 3D printed tablets with internal scaffold structure
using ethyl cellulose to achieve sustained ibuprofen release. Eur J Pharm Sci 115:11–18 Yang Y, Wu H, Fu Q, Xie X, Song Y, Xu M, Li J (2022) 3D-printed polycaprolactone-chitosan
based drug delivery implants for personalized administration. Mat Des 214:110394 Zamboulis A, Michailidou G, Koumentakou I, Bikiaris DN (2022) Polysaccharide 3D printing for
drug delivery applications. Pharmaceutics 14(1):1–32 Zein I, Hutmacher DW, Tan KC, Teoh SH (2002) Fused deposition modeling of novel scaffold
architectures for tissue engineering applications. Biomaterials 23(4):1169–1185 Zhang J, Feng X, Patil H, Tiwari RV, Repka MA (2017) Coupling 3D printing with hot-melt
extrusion to produce controlled-release tablets. Int J Pharm 519(1–2):186–197
96 S. Henry et al.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Zhang J, Xu P, Vo AQ, Bandari S, Yang F, Durig T, Repka MA (2019) Development and evaluation
of pharmaceutical 3D printability for hot melt extruded cellulose-based filaments. J Drug Deliv
Sci Technol 52:292–302 Zhang B, Nasereddin J, Mcdonagh T, Von Zeppelin D, Gleadall A, Alqahtani F, Bibb R, Belton
P, Qi S (2021) Effects of porosity on drug release kinetics of swellable and erodible porous
pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing. Int J
Pharm 604(February):120626 Zhang B, Yi X, Yan J, Gleadall A, Belton P, Bibb R (2022) Development of combi-pills using
the coupling of semi-solid syringe extrusion 3D printing with fused deposition modelling. Int J
Pharm 625(August):122140 Zhao X, Wei W, Niu R, Li Q, Hu C, Jiang S (2022) 3D printed i ntragastric floating and sustained-
release tablets with air chambers. J Pharm Sci 111(1):116–123 Zheng Y, Deng F, Wang B, Wu Y, Luo Q, Zuo X, Liu X, Cao L, Li M, Lu H, Cheng S, Li X (2021)
Melt extrusion deposition (MED™) 3D printing technology – a paradigm shift in design and
development of modified release drug products. Int J Pharm 602(January):120639